One of the Leading Research Centers in South Korea Leverages the
Medidata Clinical Cloud®
NEW YORK & SEOUL, South Korea--(BUSINESS WIRE)--Jan. 9, 2018--
(NASDAQ:MDSO), the leading global provider of cloud-based technology and
data analytics for clinical research, today announced that the Medical
Research Collaborating Center (MRCC), one of the leading research
centers of biomedical science in South Korea, has selected Medidata
Rave® to accelerate the overall regulatory data submission
process during clinical trials. MRCC, which is under the Biomedical
Research Institute of Seoul National University Hospital (SNUH), will
leverage the Medidata Clinical Cloud to facilitate clinical trials with
its partner pharmaceutical companies.
MRCC was established as a division in the Department of Education and
Research for SNUH, serving as a coordinating center for large scale
multicenter clinical trials and epidemiologic studies. By integrating
Medidata Rave, the world’s leading solution for capturing, managing and
reporting patient data, and complying with international standards such
MRCC aims to further standardize data management and statistical
analytics to meet global standards and regulatory submissions, including
those by the FDA.
“By adopting Medidata’s solution, we plan to lead innovation in the
field of life science research and strengthen our clinical research
capabilities,” said professor Hyun-jae Kang, director of Medical
Research Collaborating Center (MRCC).
Electronic data management systems that comply with global regulatory
standards are necessary for new drug submissions. With Medidata Rave,
MRCC expects to improve the process of data management and plans to make
a transition from Clinical Data Acquisition Standards Harmonization
(CDASH) to Study Data Tabulation Model (SDTM).
“We’re pleased to be facilitating new technology solutions for the
Medical Research Collaborating Center of Seoul National University
Hospital, one of the leading research centers of biomedical science in
South Korea,” said Edwin Ng, vice president of field operations of APeJ,
Medidata. "The effective management and collection of clinical trial
data is necessary to meet regulatory standards, and accelerates the
delivery of new solutions to patients around the world. We’re proud to
be the comprehensive cloud platform selected by global pharmaceutical
companies to not only meet their research goals, but exceed them.”
is reinventing global drug and medical device development by creating
the industry's leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including over 950 global pharmaceutical companies, biotech,
diagnostic and device firms, leading academic medical centers, and
contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make more
informed decisions earlier and faster. Our unparalleled clinical trial
data assets provide deep insights that pave the way for future growth.
The Medidata Clinical Cloud is the primary technology solution powering
clinical trials for 18 of the world's top 25 global pharmaceutical
companies and is used by 18 of the top 25 medical device developers—from
study design and planning through execution, management and reporting.
1The Clinical Data Interchange Standards Consortium (CDISC)
is an international, non-profit organization that develops and supports
global data standards for clinical research.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180109005551/en/
D’Amico, +1 732-767-4331
Snider, +1 646-362-2997